Bentham Science Logo

Track Your Manuscript:


Current Radiopharmaceuticals

Volume 15, 4 Issues, 2022
ISSN: 1874-4729 (Online)
ISSN: 1874-4710 (Print)
This journal supports open access

Meet the Executive Guest Editor(s)

Alaa Abd-Elsayed
Department of Anesthesiology
University of Wisconsin-Madison
Madison,WI
(USA)
Dr. Alaa Abd-Elsayed joined the faculty of the Anesthesiology Department at the University of Wisconsin in 2014 to provide Chronic Pain Medicine Services as part of the Interventional Pain Program. He completed a master’s degree in Public Health, research fellowship at Cleveland Clinic, and residency in anesthesiology and pain management fellowship from University of Cincinnati. As part of the Interventional Pain Program, Dr. Abd-Elsayed evaluates patients at the Pain Clinic. In addition, Dr. Abd-Elsayed is an active clinical investigator. Current studies include the use of opioids, genetic variations leading to different individual responses to opioids, and the use of neuromodulation and peripheral nerve stimulators for the management of neuropathic pain. He also has research interests in fibromyalgia, complex regional pain syndrome (CRPS) and headaches, and is leading a study called "CREATE" to help CRPS patients. Over the course of his career, he has received numerous research grants, published more than 70 peer-reviewed manuscripts and authored several editorials and book chapters. He has presented at more than 60 international and national conferences and has earned more than 15 awards at the state and national levels. In addition, he has served as a reviewer for more than 20 journals and as an editor to several journals. Dr. Abd-Elsayed, as he likes to be called, is a member of the American Society of Interventional Pain Physicians (ASIPP) and the American Society of Regional Anesthesia and Pain Medicine (ASRA). He was named among the Leading Physicians of the World and America's Best Physicians in 2016.


Amir R. Jalilian
Department of Nuclear Sciences and Applications
International Atomic Energy Agency (IAEA)
Vienna
(Austria)
Prof. Amir R. Jalilian has a PharmD. degree (1995), a PhD degree in Radiopharmacy (2000) followed by Postdoctoral fellowships from the University of Alberta, Canada and Yale School of Medicine, CT, USA. Until 2015, he was active in the development of new radiopharmaceuticals leading to the completion of clinical trials and the marketing of six radiopharmaceuticals. He has published around 300 scientific papers in peer-viewed journals and five books in various languages and supervised more than 50 MSc and PhD thesis. In 2015, he joined the Nuclear Sciences and Application Department, International Atomic Energy Agency (IAEA), Vienna Headquarters, Austria as a Radioisotope/Radiopharmaceutical Chemist. He is leading four IAEA international Collaborated Research Projects (CRP) on the topic of radioisotope and radiopharmaceutical production.


Sombat Muengtaweepongsa
Faculty of Medicine
Thammasat University
Bangkok
(Thailand)
Dr.Sombat Muengtaweepongsa received his MD degree from the Ramathibodi Hospital Mahidol University, Bangkok, Thailand. And Dr. Muengtaweepongsa completed clinical fellowship training in Cerebrovascular and Critical care Neurology at the Saint Louis University, Missouri, USA. Dr. Muengtaweepongsa pursued an Academic career at the Department of Medicine, Faculty of Medicine, Thammasat University, as Associate Professor, Head of the Neurology Division (2008 - 2011), Chairman of the Department of Medicine (2011 – 2018) and Associate Dean for Research Affairs (2018-now). Dr. Muengtaweepongsa established the Stroke Fast Track and Stroke Unit (2008 - now) at Thammasat University Hospital where he served in Executive Director, Department Head positions focusing on stroke/CNS, thrombosis and targeted temperature management (TTM). Dr. Muengtaweepongsa is acknowledged for a pioneer of Stroke Network and Therapeutic Hypothermia for the treatment of Post-Cardiac Arrest and Critical Neurologic Conditions in Thailand. Dr. Muengtaweepongsa is listed on 2 patents, more than 20 edited books and authored and co-authored over 100 publications of which over 80 published in peer-reviewed scientific professional journals. Dr. Muengtaweepongsa served on editorial boards of many scientific journals (Journal of Interventional Neuroradiology, Frontiers in Neurology, World journal of Methodology). In the past 5 years, Dr. Muengtaweepongsa's work focused on research areas in Cerebrovascular and Critical care Neurology particularly targeted temperature management and stroke.


Editor-in-Chief

Andrea Ciarmiello
Chief of Nuclear Medicine Unit and Imaging Department
S. Andrea Hospital
La Spezia
(Italy)
Biography
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Radiopharmaceuticals was launched in 2008 with the assistance of Dr. Sean L. Kitson who served as the Editor-in-Chief of the journal till 2021. The current Editor-in-Chief, Prof. Dr. Andrea Ciarmiello, took charge of the journal from June 2021.

Related Journals

Related eBooks

eBooks Catalog